Characteristics of patients with IA with or without CVD-related hospital admissions. Values are % unless otherwise specified.
| Characteristics | Yes, n = 270 | No, n = 2345 | p |
|---|---|---|---|
| Female | 56 | 65 | < 0.001 |
| Age, yrs, mean (SD) | 62 (13) | 54 (15) | < 0.001 |
| Followup NIVEL PCD, yrs, median (IQR) | 3.9 (1.9–6.0) | 2.9 (1.4–4.9) | < 0.001 |
| Followup DHD, yrs, median (IQR) | 5.7 (3.2–7.5) | 4.0 (2.6–6.6) | < 0.001 |
| No. chronic diseases at inclusion | |||
| 0 | 19 | 31 | |
| 1 | 19 | 26 | |
| 2 | 22 | 18 | |
| 3 | 15 | 11 | |
| ≥ 4 | 25 | 14 | < 0.001 |
| Antihypertensive agents | |||
| Beta-blocking agents (C07A) | 30 | 16 | < 0.001 |
| ACE inhibitors, plain (C09A) | 18 | 10 | < 0.001 |
| Low-ceiling diuretics, thiazides (C03A) | 15 | 8 | < 0.001 |
| Selective calcium channel blockers with mainly vascular effects (C08C) | 9 | 7 | 0.151 |
| High-ceiling diuretics (C03C) | 10 | 5 | < 0.001 |
| Lipid-lowering agents | |||
| Lipid-modifying agents, plain (C10A) | 25 | 13 | < 0.001 |
IA: inflammatory arthritis; CVD: cardiovascular disease; NIVEL PCD: The Netherlands Institute for Health Services Research Primary Care Database; IQR: interquartile range; DHD: The Dutch Hospital Data; ACE: angiotensin-converting enzyme.